These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 37843493)
1. Evaluation of Ocular and Systemic Oxidative Stress Markers in Ocular Rosacea Patients. Yesilirmak N; Bukan N; Kurt B; Yuzbasioglu S; Zhao M; Rodrigues-Braz D; Aktas A; Behar-Cohen F; Bourges JL Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):22. PubMed ID: 37843493 [TBL] [Abstract][Full Text] [Related]
2. Toll-like receptor-4 expression and oxidative stress in ocular rosacea. Yesilirmak N; Bukan N; Kurt B; Fatsa T; Yuzbasıoglu S; Zhao M; Hosbul T; Bourges JL; Behar-Cohen F Mol Vis; 2023; 29():357-364. PubMed ID: 38577560 [TBL] [Abstract][Full Text] [Related]
3. Objective optical assessment of tear-film quality dynamics in patients with meibomian gland dysfunction and aqueous-deficient dry eye optical quality changes in different dry eye subtypes. Ye F; Jiang F; Lu Y; Xue CY; Zhu XM; Wu Y; Huang ZP Indian J Ophthalmol; 2019 May; 67(5):599-603. PubMed ID: 31007216 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of intense pulsed light treatment on the ocular surface in patients with rosacea-associated meibomian gland dysfunction. Seo KY; Kang SM; Ha DY; Chin HS; Jung JW Cont Lens Anterior Eye; 2018 Oct; 41(5):430-435. PubMed ID: 29958778 [TBL] [Abstract][Full Text] [Related]
5. Assessment of Tear Functions in Patients with Acne Rosacea without Meibomian Gland Dysfunction. Ozek D; Evren Kemer Ö; Artüz F Ocul Immunol Inflamm; 2019; 27(4):632-635. PubMed ID: 29533687 [No Abstract] [Full Text] [Related]
6. Investigation of Thiol/Disulfide Homeostasis and Clinical Parameters in Rosacea Patients According to Skin Subtypes. Yesilirmak N; Saritas O; Kurt B; Neselioglu S; Aktas A; Erel O J Clin Med; 2024 Jul; 13(14):. PubMed ID: 39064093 [No Abstract] [Full Text] [Related]
7. Automated Measurement of Tear Film Dynamics and Lipid Layer Thickness for Assessment of Non-Sjögren Dry Eye Syndrome With Meibomian Gland Dysfunction. Ji YW; Lee J; Lee H; Seo KY; Kim EK; Kim TI Cornea; 2017 Feb; 36(2):176-182. PubMed ID: 28060064 [TBL] [Abstract][Full Text] [Related]
8. Morphological and Functional Evaluation of Meibomian Gland Dysfunction in Rosacea Patients. Machalińska A; Zakrzewska A; Markowska A; Safranow K; Wiszniewska B; Parafiniuk M; Machaliński B Curr Eye Res; 2016 Aug; 41(8):1029-1034. PubMed ID: 26644191 [TBL] [Abstract][Full Text] [Related]
9. Influence of video display terminal use and meibomian gland dysfunction on the ocular surface and tear neuromediators. Bilgic AA; Kocabeyoglu S; Dikmetas O; Tan C; Karakaya J; Irkec M Int Ophthalmol; 2023 May; 43(5):1537-1544. PubMed ID: 36239837 [TBL] [Abstract][Full Text] [Related]
10. A standardized visual scale for evaluation of tear fluorescein clearance. Macri A; Rolando M; Pflugfelder S Ophthalmology; 2000 Jul; 107(7):1338-43. PubMed ID: 10889108 [TBL] [Abstract][Full Text] [Related]
11. Evaluation of incomplete blinking as a measurement of dry eye disease. Jie Y; Sella R; Feng J; Gomez ML; Afshari NA Ocul Surf; 2019 Jul; 17(3):440-446. PubMed ID: 31152804 [TBL] [Abstract][Full Text] [Related]
12. Advanced oxidation protein products and serum total oxidant/antioxidant status levels in rosacea. Erdogan HK; Bulur I; Kocaturk E; Saracoglu ZN; Alatas O; Bilgin M Postepy Dermatol Alergol; 2018 Jun; 35(3):304-308. PubMed ID: 30008650 [TBL] [Abstract][Full Text] [Related]
13. Corneal Epithelial Dendritic Cells: An Objective Indicator for Ocular Surface Inflammation in Patients with Obstructive Meibomian Gland Dysfunction? Chen Q; Wang L; Zhang Y; Xu X; Wei Z; Zhang Z; Wei Y; Pang J; Guo X; Cao K; Liang Q Ocul Immunol Inflamm; 2024 Jan; 32(1):79-88. PubMed ID: 36622888 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of dry eye and meibomian gland dysfunction with meibography in patients with rosacea. Palamar M; Degirmenci C; Ertam I; Yagci A Cornea; 2015 May; 34(5):497-9. PubMed ID: 25826323 [TBL] [Abstract][Full Text] [Related]
15. Increased Tear Fluid Production as a Compensatory Response to Meibomian Gland Loss: A Multicenter Cross-sectional Study. Arita R; Morishige N; Koh S; Shirakawa R; Kawashima M; Sakimoto T; Suzuki T; Tsubota K Ophthalmology; 2015 May; 122(5):925-33. PubMed ID: 25626757 [TBL] [Abstract][Full Text] [Related]
16. Influence of Meibomian Gland Dysfunction and Friction-Related Disease on the Severity of Dry Eye. Vu CHV; Kawashima M; Yamada M; Suwaki K; Uchino M; Shigeyasu C; Hiratsuka Y; Yokoi N; Tsubota K; Ophthalmology; 2018 Aug; 125(8):1181-1188. PubMed ID: 29459039 [TBL] [Abstract][Full Text] [Related]
17. A Retrospective Study of Treatment Outcomes and Prognostic Factors of Intense Pulsed Light Therapy Combined With Meibomian Gland Expression in Patients With Meibomian Gland Dysfunction. Tang Y; Liu R; Tu P; Song W; Qiao J; Yan X; Rong B Eye Contact Lens; 2021 Jan; 47(1):38-44. PubMed ID: 32282398 [TBL] [Abstract][Full Text] [Related]
18. Meibomian Gland Morphology Is a Sensitive Early Indicator of Meibomian Gland Dysfunction. Adil MY; Xiao J; Olafsson J; Chen X; Lagali NS; Ræder S; Utheim ØA; Dartt DA; Utheim TP Am J Ophthalmol; 2019 Apr; 200():16-25. PubMed ID: 30578784 [TBL] [Abstract][Full Text] [Related]
19. Intense pulsed light improves signs and symptoms of dry eye disease due to meibomian gland dysfunction: A randomized controlled study. Toyos R; Desai NR; Toyos M; Dell SJ PLoS One; 2022; 17(6):e0270268. PubMed ID: 35737696 [TBL] [Abstract][Full Text] [Related]
20. Meibomian gland dysfunction is the primary determinant of dry eye symptoms: Analysis of 2346 patients. Teo CHY; Ong HS; Liu YC; Tong L Ocul Surf; 2020 Oct; 18(4):604-612. PubMed ID: 32682082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]